Clinical trials
Phase 2 Alzheimer Disease trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chang Gung Memorial Hospital | 6 |
| Fujian Medical University Union Hospital | 2 |
| The Methodist Hospital Research Institute | 2 |
| Zhejiang Hisun Pharmaceutical Co. Ltd. | 2 |
| APRINOIA Therapeutics, LLC | 1 |
| Aphios | 1 |
| Blanchette Rockefeller Neurosciences Insitute | 1 |
| Changchun Huayang High-tech Co., Ltd | 1 |
| Cyclo Therapeutics, Inc. | 1 |
| Dongzhimen Hospital, Beijing | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 40 |
| Cognitive Dysfunction | 7 |
| Dementia | 3 |
| Frontotemporal Dementia | 2 |
| Memory Disorders | 2 |
| Plaque, Amyloid | 2 |
| Amyloidosis | 1 |
| Atherosclerosis | 1 |
| Autoimmune Diseases | 1 |
| Brain Injuries, Traumatic | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.